Obstructive sleep apnea: management considerations in psychiatric patients

Taryn Heck,1 Monica Zolezzi21Pharmacy Department, University of Alberta Hospital, Alberta Health Services, Edmonton, AB, Canada; 2Clinical Pharmacy and Practice, College of Pharmacy, Qatar University, Doha, QatarAbstract: Psychiatric disorders and obstructive sleep apnea (OSA) are often com...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Heck T, Zolezzi M
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/16c8298a9453461288501cc5b1be7a7c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:16c8298a9453461288501cc5b1be7a7c
record_format dspace
spelling oai:doaj.org-article:16c8298a9453461288501cc5b1be7a7c2021-12-02T00:55:49ZObstructive sleep apnea: management considerations in psychiatric patients1178-2021https://doaj.org/article/16c8298a9453461288501cc5b1be7a7c2015-10-01T00:00:00Zhttps://www.dovepress.com/obstructive-sleep-apnea-management-considerations-in-psychiatric-patie-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Taryn Heck,1 Monica Zolezzi21Pharmacy Department, University of Alberta Hospital, Alberta Health Services, Edmonton, AB, Canada; 2Clinical Pharmacy and Practice, College of Pharmacy, Qatar University, Doha, QatarAbstract: Psychiatric disorders and obstructive sleep apnea (OSA) are often comorbid. However, there is limited information on the impact of psychotropic medications on OSA symptoms, on how to manage psychiatric pharmacotherapy in patients presenting with OSA, or on the effectiveness and challenges of OSA treatments in patients with comorbid mental illness. As such, the objective of this article is to provide an overview of some epidemiological aspects of OSA and treatment considerations in the management of OSA in individuals with comorbid psychiatric disorders. Predefined keywords were used to search for relevant literature in electronic databases. Data show that OSA is particularly prevalent in patients with psychiatric disorders. The medical care that patients with these comorbidities require can be challenging, as some of the psychiatric medications used by these patients may exacerbate OSA symptoms. As such, continuous positive airway pressure continues to be the first-line treatment, even in patients with psychiatric comorbidity. However, more controlled studies are required, particularly to determine continuous positive airway pressure compliance in patients with mental illness, the impact of treating OSA on psychiatric symptoms, and the impact of the use of psychotropic medications on OSA symptoms.Keywords: obstructive sleep apnea, psychiatric disorders, comorbidity, psychotropic medicationsHeck TZolezzi MDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2015, Iss default, Pp 2691-2698 (2015)
institution DOAJ
collection DOAJ
language EN
topic Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Heck T
Zolezzi M
Obstructive sleep apnea: management considerations in psychiatric patients
description Taryn Heck,1 Monica Zolezzi21Pharmacy Department, University of Alberta Hospital, Alberta Health Services, Edmonton, AB, Canada; 2Clinical Pharmacy and Practice, College of Pharmacy, Qatar University, Doha, QatarAbstract: Psychiatric disorders and obstructive sleep apnea (OSA) are often comorbid. However, there is limited information on the impact of psychotropic medications on OSA symptoms, on how to manage psychiatric pharmacotherapy in patients presenting with OSA, or on the effectiveness and challenges of OSA treatments in patients with comorbid mental illness. As such, the objective of this article is to provide an overview of some epidemiological aspects of OSA and treatment considerations in the management of OSA in individuals with comorbid psychiatric disorders. Predefined keywords were used to search for relevant literature in electronic databases. Data show that OSA is particularly prevalent in patients with psychiatric disorders. The medical care that patients with these comorbidities require can be challenging, as some of the psychiatric medications used by these patients may exacerbate OSA symptoms. As such, continuous positive airway pressure continues to be the first-line treatment, even in patients with psychiatric comorbidity. However, more controlled studies are required, particularly to determine continuous positive airway pressure compliance in patients with mental illness, the impact of treating OSA on psychiatric symptoms, and the impact of the use of psychotropic medications on OSA symptoms.Keywords: obstructive sleep apnea, psychiatric disorders, comorbidity, psychotropic medications
format article
author Heck T
Zolezzi M
author_facet Heck T
Zolezzi M
author_sort Heck T
title Obstructive sleep apnea: management considerations in psychiatric patients
title_short Obstructive sleep apnea: management considerations in psychiatric patients
title_full Obstructive sleep apnea: management considerations in psychiatric patients
title_fullStr Obstructive sleep apnea: management considerations in psychiatric patients
title_full_unstemmed Obstructive sleep apnea: management considerations in psychiatric patients
title_sort obstructive sleep apnea: management considerations in psychiatric patients
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/16c8298a9453461288501cc5b1be7a7c
work_keys_str_mv AT heckt obstructivesleepapneamanagementconsiderationsinpsychiatricpatients
AT zolezzim obstructivesleepapneamanagementconsiderationsinpsychiatricpatients
_version_ 1718403365349621760